SUBSCRIBE
SUBSCRIBE
News   FDA

Novartis Corporation’s MS Drug Gets Approval in EU

May 27, 2008 | 
1 min read
ZURICH, May 26 (Reuters) - Swiss drugmaker Novartis said on Monday its Extavia multiple sclerosis drug had been approved in the European Union and repeated that it planned to launch Extavia in the U.S. and Europe in the first half of 2009.
FDA Approvals Europe
MORE ON THIS TOPIC
Black box mockup for cosmetics, perfume, presentation with shadows, isolated on background. Product photo for advertising package. Template for stylish cardboard packaging for goods.
Government
Cassidy Names Areas of Improvement for FDA’s Regulatory ‘Black Box’
February 19, 2026
 · 
3 min read
 · 
Tristan Manalac
Document checking, agreement or contract validation, financial or budget analysis, search for document files concept, businessman manager holding big magnifying glass checking document paper.
Regulatory
It’s Official: FDA Will Now Default to One Clinical Trial for Drug Applications
February 19, 2026
 · 
3 min read
 · 
Tristan Manalac
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
FDA
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision
February 18, 2026
 · 
3 min read
 · 
Heather McKenzie
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
 · 
1 min read
 · 
Heather McKenzie